Patanase and Ventolin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Patanase (olopatadine hydrochloride) and Ventolin (albuterol). Common drug interactions include dyspnoea among females and insomnia among males.

The phase IV clinical study analyzes what interactions people have when they take Patanase and Ventolin. It is created by eHealthMe based on reports of 40 people who take the same drugs from the FDA, and is updated regularly.

What is Patanase?

Patanase has active ingredients of olopatadine hydrochloride. It is often used in allergies. eHealthMe is studying from 1,514 Patanase users. Check the latest studies of Patanase.

What is Ventolin?

Ventolin has active ingredients of albuterol. It is often used in asthma. eHealthMe is studying from 51,849 Ventolin users. Check the latest studies of Ventolin.



On Aug, 01, 2026

40 people who take Patanase and Ventolin together, and have interactions are studied.

Patanase and Ventolin drug interactions.

What are the common drug interactions of Patanase and Ventolin, by gender? *:

female:

  1. Dyspnoea (difficult or laboured respiration)
  2. Pneumonia
  3. Throat tightness
  4. Urticaria (rash of round, red welts on the skin that itch intensely)
  5. Blood pressure decreased
  6. Blindness
  7. Blood pressure increased
  8. Headache (pain in head)
  9. Adverse drug reaction
  10. Cough

male:

  1. Insomnia (sleeplessness)
  2. Anaphylactic reaction (serious allergic reaction)
  3. Headache (pain in head)
  4. Drug ineffective
  5. Dyspnoea (difficult or laboured respiration)
  6. Eye pain
  7. Myalgia (muscle pain)
  8. Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
  9. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  10. Conjunctivitis allergic (inflammation of the conjunctiva due to allergy)

What are the common drug interactions of Patanase and Ventolin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Headache (pain in head)
  2. Rhinorrhoea (watery mucus discharge from the nose)
  3. Sinusitis (inflammation of sinus)
  4. Swelling

10-19:

  1. Anger
  2. Dyspnoea (difficult or laboured respiration)
  3. Fatigue (feeling of tiredness)
  4. Hallucination, auditory (perceiving sounds without auditory stimulus)
  5. Insomnia (sleeplessness)
  6. Respiratory tract infection viral

20-29:

n/a

30-39:

  1. Anaphylactic reaction (serious allergic reaction)
  2. Back injury
  3. Dysphonia (speech disorder attributable to a disorder of phonation)
  4. Hypersensitivity
  5. Insomnia (sleeplessness)
  6. Lethargy (tiredness)
  7. Nasal discharge discolouration (change in colour of nasal discharge)
  8. Nasal polyps (masses that develop in the lining of the nose)
  9. Rhinitis (a medical term for irritation and inflammation of the mucous membrane inside the nose)
  10. Toothache (tooth pain)

40-49:

  1. Alopecia (absence of hair from areas of the body)
  2. Anaphylactic reaction (serious allergic reaction)
  3. Bladder prolapse (bulging of one or more of the pelvic organs into the vagina)
  4. Fatigue (feeling of tiredness)
  5. Limb injury
  6. Oesophageal irritation
  7. Peripheral nerve injury
  8. Rotator cuff syndrome (a spectrum of conditions affecting the rotator cuff tendons of the shoulder)
  9. Uterine prolapse
  10. Vision blurred

50-59:

  1. Dyspnoea (difficult or laboured respiration)
  2. Throat tightness
  3. Urticaria (rash of round, red welts on the skin that itch intensely)
  4. Blood pressure decreased
  5. Blindness
  6. Blood pressure increased
  7. Headache (pain in head)
  8. Pneumonia
  9. Cough
  10. Throat irritation

60+:

  1. Drug ineffective
  2. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  3. Arthralgia (joint pain)
  4. Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
  5. Cellulitis (infection under the skin)
  6. Chills (felling of cold)
  7. Chronic kidney disease
  8. Constipation
  9. Decreased appetite
  10. Dizziness

What are the existing conditions these people have? *

  1. Hypersensitivity: 10 people, 25.00%
  2. Depression: 7 people, 17.50%
  3. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 12.50%
  4. Immunodeficiency Common Variable: 5 people, 12.50%
  5. High Blood Pressure: 4 people, 10.00%
  6. High Blood Cholesterol: 4 people, 10.00%
  7. Stable Angina (a constant chest pain): 3 people, 7.50%
  8. Cardiac Disorder: 3 people, 7.50%
  9. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 3 people, 7.50%
  10. Myasthenia Gravis (a chronic condition that causes muscles to tire and weaken easily): 3 people, 7.50%

* Approximation only. Some reports may have incomplete information.

Do you take Patanase and Ventolin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Patanase and Ventolin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Patanase:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ventolin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Patanase and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ventolin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on olopatadine hydrochloride and albuterol (the active ingredients of Patanase and Ventolin, respectively), and Patanase and Ventolin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: